<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/287a" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/287a/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/287a/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_287a"><akn:num>287a</akn:num><akn:heading>Cures Acceleration Network</akn:heading><akn:content><akn:p>§ 287a. Cures Acceleration Network(a) DefinitionsIn this section:(1) Biological productThe term “biological product” has the meaning given such term in section 262 of this title.


(2) Drug; deviceThe terms “drug” and “device” have the meanings given such terms in section 321 of title 21.


(3) High need cureThe term “high need cure” means a drug (as that term is defined by section 321(g)(1) of title 21,11 So in original. A closing parenthesis probably should precede the comma. biological product (as that term is defined by section 262(i) 22 See References in Text note below. of this title), or device (as that term is defined by section 321(h) of title 21) that, in the determination of the Director of the Center—(A) is a priority to diagnose, mitigate, prevent, or treat harm from any disease or condition; and

(B) for which the incentives of the commercial market are unlikely to result in its adequate or timely development.


(4) Medical productThe term “medical product” means a drug, device, biological product, or product that is a combination of drugs, devices, and biological products.



(b) Establishment of the Cures Acceleration NetworkSubject to the appropriation of funds as described in subsection (g), there is established within the Center a program to be known as the Cures Acceleration Network (referred to in this section as “CAN”), which shall—(1) be under the direction of the Director of the Center, taking into account the recommendations of a CAN Review Board (referred to in this section as the “Board”), described in subsection (d); and

(2) award grants and contracts to eligible entities, as described in subsection (e), to accelerate the development of high need cures, including through the development of medical products and behavioral therapies.


(c) FunctionsThe functions of the CAN are to—(1) conduct and support revolutionary advances in basic research, translating scientific discoveries from bench to bedside;

(2) award grants and contracts to eli</akn:p></akn:content><akn:subsection eId="subsec_287a_a"><akn:num>(a)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(a) Definitions In this section:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_287a_b"><akn:num>(b)</akn:num><akn:heading>Establishment of the Cures Acceleration Network</akn:heading><akn:content><akn:p>(b) Establishment of the Cures Acceleration Network Subject to the appropriation of funds as described in subsection (g), there is established within the Center a program to be known as the Cures Acceleration Network (referred to in this section as “CAN”), which shall—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_287a_c"><akn:num>(c)</akn:num><akn:heading>Functions</akn:heading><akn:content><akn:p>(c) Functions The functions of the CAN are to—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_287a_d"><akn:num>(d)</akn:num><akn:heading>CAN Board</akn:heading><akn:content><akn:p>(d) CAN Board</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_287a_e"><akn:num>(e)</akn:num><akn:heading>Grant program</akn:heading><akn:content><akn:p>(e) Grant program</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_287a_f"><akn:num>(f)</akn:num><akn:heading>Competitive basis of awards</akn:heading><akn:content><akn:p>(f) Competitive basis of awards Any grant, cooperative agreement, or contract awarded under this section shall be awarded on a competitive basis.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_287a_g"><akn:num>(g)</akn:num><akn:heading>Authorization of appropriations</akn:heading><akn:content><akn:p>(g) Authorization of appropriations</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>